Definium Therapeutics Shares Rally 190% YTD on Positive Phase 2 LSD Trial Data
Definium Therapeutics shares climb as synthetic LSD treatment shows superior efficacy in Phase 2 anxiety trials, marking another milestone for the biotech…
Definium Therapeutics shares climb as synthetic LSD treatment shows superior efficacy in Phase 2 anxiety trials, marking another milestone for the biotech…
A cluster of suicides in the US Cyber Command unit triggers internal reviews and spotlights military mental health challenges, with potential long-term…
Nearly two-thirds of young male daily stock traders feel like failures, underscoring the psychological risks of high-frequency retail trading in an environment…